Carbonate ion
- Generic Name
- Carbonate ion
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- CO3
- CAS Number
- 3812-32-6
- Unique Ingredient Identifier
- 7UJQ5OPE7D
- Associated Conditions
- -
- Associated Therapies
- -
Unicycive Therapeutics Announces Submission of the New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis
Unicycive Therapeutics submitted an NDA to the FDA for Oxylanthanum Carbonate (OLC) to treat hyperphosphatemia in CKD patients on dialysis. OLC aims to reduce pill burden and improve patient compliance. The submission is based on clinical and preclinical studies, with potential market opportunities exceeding $2.5 billion globally.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath